Quarterly report pursuant to Section 13 or 15(d)

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.20.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS        
Revenue $ 1,193 $ 237 $ 2,456 $ 394
Operating expenses        
Research and development (including losses accrued on firm purchase commitments of $0, $5,000, $0 and $5,000) (24,067) (29,617) (65,791) (77,147)
General and administrative (13,001) (10,741) (32,557) (32,662)
Total operating expenses (37,068) (40,358) (98,348) (109,809)
Operating loss (35,875) (40,121) (95,892) (109,415)
Interest income 2,147 615 4,024 2,324
Other (expense) income, net (1,689) 291 (1,501) (556)
Loss before income taxes (35,417) (39,215) (93,369) (107,647)
Income tax expense (15) (87) (110) (154)
Net loss attributable to ordinary shareholders $ (35,432) $ (39,302) $ (93,479) $ (107,801)
Net loss per ordinary share - Basic and diluted        
Basic and diluted (in dollars per share) $ (0.04) $ (0.06) $ (0.11) $ (0.17)
Weighted average shares outstanding:        
Basic and diluted (in shares) 928,022,057 630,866,800 829,973,177 629,403,293